{"gene":"CASP2","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1994,"finding":"ICH-1L (the long form of CASP2) induces programmed cell death when overexpressed, while the alternatively spliced short form ICH-1S suppresses serum deprivation-induced cell death, demonstrating that CASP2 encodes both positive and negative regulators of apoptosis via alternative splicing.","method":"Overexpression in mammalian cells; serum deprivation apoptosis assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — original functional characterization replicated across constructs, foundational paper with 822 citations","pmids":["8087842"],"is_preprint":false},{"year":1994,"finding":"Nedd2/CASP2 overexpression induces apoptosis in fibroblast and neuroblastoma cells, and this death is suppressed by BCL-2, placing CASP2 downstream of BCL-2 in the programmed cell death pathway.","method":"Overexpression and genetic epistasis in cultured cells; BCL-2 co-expression rescue","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — epistasis with BCL-2, replicated by multiple labs, 600 citations","pmids":["7958843"],"is_preprint":false},{"year":1995,"finding":"CASP2/Nedd2, together with ICE (CASP1), cleaves PARP in a manner identical to apoptotic cleavage; in vitro, recombinant ICE cleaves PARP in a time- and enzyme-concentration-dependent manner, though requiring 50–100-fold higher concentration than for IL-1β processing.","method":"COS cell co-transfection assay; in vitro cleavage with purified recombinant enzyme","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified enzyme plus cellular co-expression assay","pmids":["7642516"],"is_preprint":false},{"year":1995,"finding":"Antisense suppression of Nedd2/CASP2 in FDC-P1 cells significantly inhibits apoptosis upon cytokine withdrawal, demonstrating a direct role for CASP2 in mediating apoptosis.","method":"Antisense Nedd2 expression; cell death assay upon cytokine removal","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined cellular phenotype, single lab","pmids":["7615091"],"is_preprint":false},{"year":1996,"finding":"The pro-Nedd2/CASP2 precursor (p51) is processed in vitro by CPP32 (caspase-3), ICE, and granzyme B into p19 and p12 subunits, indicating that CASP2 activation requires cleavage by upstream ICE-like proteases and that CASP2 may be a downstream effector in CTL-mediated killing.","method":"In vitro processing assay with purified caspases and granzyme B; cell extract processing assays","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 1 — in vitro cleavage with purified enzymes, multiple proteases tested","pmids":["9078393"],"is_preprint":false},{"year":1997,"finding":"CASP2/Nedd2 is activated early during apoptosis induced by diverse stimuli, preceding caspase-3 (CPP32) activation, consistent with CASP2 being an upstream initiator caspase.","method":"Western blot detection of processed CASP2 in cells treated with apoptotic agents; temporal comparison with caspase-3 activation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — temporal ordering with multiple stimuli, single lab","pmids":["9148927"],"is_preprint":false},{"year":1997,"finding":"Nedd2/CASP2 is required for apoptosis induced by trophic factor withdrawal in PC12 cells and sympathetic neurons, but not for apoptosis caused by SOD1 downregulation, demonstrating stimulus-specific roles for distinct caspases.","method":"Antisense oligonucleotide knockdown; cell death and immunohistochemical assays in neurons and PC12 cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with specific phenotypic readouts and stimulus specificity, replicated across cell types","pmids":["9045720"],"is_preprint":false},{"year":1997,"finding":"RAIDD (CRADD) is an adaptor molecule that directly binds to caspase-2 via homophilic CARD–CARD (prodomain) interaction, and also binds to the death domain-containing kinase RIP, linking CASP2 to upstream death signaling pathways.","method":"Yeast two-hybrid and immunoprecipitation; domain mapping","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding confirmed with domain mapping, 455 citations, replicated","pmids":["8985253"],"is_preprint":false},{"year":1997,"finding":"CRADD contains an N-terminal caspase homology domain that specifically interacts with caspase-2, and a C-terminal death domain that interacts with RIP, establishing CRADD as a bipartite adaptor bridging RIP and CASP2 in apoptotic signaling.","method":"Co-immunoprecipitation; domain deletion analysis; apoptosis assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with domain mapping, independently corroborated by Duan & Dixit","pmids":["9044836"],"is_preprint":false},{"year":1998,"finding":"The RAIDD CARD structure was solved by NMR and shown to consist of six helices arranged in a death-domain topology; mutagenesis of basic and acidic surface patches on opposite sides of RAIDD CARD and ICH-1/CASP2 CARD mediate their homophilic CARD–CARD interaction.","method":"NMR structure determination; mutagenesis; homology modeling","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — NMR structure plus mutagenesis with functional validation","pmids":["9695946"],"is_preprint":false},{"year":1998,"finding":"The pro-Nedd2/CASP2 precursor dimerizes prior to autoprocessing; both the prodomain and C-terminal residues are required for dimerization, and dimerization occurs before cleavage of the catalytic subunits as shown in yeast.","method":"Yeast-based dimerization assay; aspartate-to-alanine mutants; in vitro processing by recombinant active Nedd2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in yeast plus in vitro processing, mutagenesis of critical aspartates","pmids":["9506977"],"is_preprint":false},{"year":1998,"finding":"The prodomain of CASP2 is required for nuclear localization of the precursor; GFP-fused prodomain alone localizes to nuclear dot- and fiber-like structures, and fusing the CASP2 prodomain to the normally cytoplasmic caspase-3 mediates its nuclear transport.","method":"GFP fusion constructs; live fluorescence microscopy; subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct imaging with functional domain swaps, clear mechanistic conclusion","pmids":["9733748"],"is_preprint":false},{"year":1998,"finding":"CASP2 processing at D333 occurs independently of caspase-3-like activity during trophic factor withdrawal; caspase-2 is required for death but caspase-3-like activity is neither necessary nor sufficient, placing CASP2 in a parallel or independent branch from caspase-3.","method":"Western blot for CASP2 processing; selective caspase inhibitors (DEVD-FMK vs BAF/zVAD); antisense to CASP2; enzymatic activity assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal pharmacological and genetic approaches, clear epistasis","pmids":["9801360"],"is_preprint":false},{"year":1998,"finding":"ARC (apoptosis repressor with CARD) interacts selectively with caspase-2 (and caspase-8, CED-3) but not caspase-1, -3, or -9, via CARD–CARD interaction, and inhibits caspase-2-induced apoptosis; ARC is expressed primarily in skeletal muscle and heart.","method":"Immunoprecipitation; co-transfection apoptosis assays; enzymatic inhibition assay in 293T cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with selectivity controls, functional inhibition assay","pmids":["9560245"],"is_preprint":false},{"year":2000,"finding":"Caspase-2 localizes to the Golgi complex (in addition to nucleus) and cleaves golgin-160 at a unique site not cleaved by other caspases with similar peptide specificities; prevention of this cleavage delays Golgi disintegration during apoptosis.","method":"Subcellular fractionation; immunofluorescence microscopy; in vitro cleavage assays; mutagenesis of golgin-160 cleavage site; apoptotic morphology assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (localization, in vitro cleavage, mutagenesis, functional rescue), rigorous controls","pmids":["10791974"],"is_preprint":false},{"year":2002,"finding":"Caspase-2 is required upstream of mitochondria for cytotoxic stress-induced apoptosis; it is activated before mitochondrial permeabilization and is necessary for cytochrome c release, establishing CASP2 as an initiator that acts upstream of the mitochondrial amplification step.","method":"Caspase-2 inhibitors and dominant-negative constructs; cytochrome c release assay; epistasis with mitochondrial pathway","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological epistasis, replicated independently (Guo et al. and Robertson et al. same year), 592 citations","pmids":["12193789"],"is_preprint":false},{"year":2002,"finding":"Caspase-2 induces cytochrome c, AIF, and Smac release from isolated mitochondria independently of Bid or cytosolic factors; it also cleaves cytosolic Bid, which then triggers cytochrome c release; Bcl-2 and Bcl-xL block caspase-2-induced death; unlike caspase-8, caspase-2 cannot directly process other caspase zymogens.","method":"Purified recombinant caspase-2; isolated mitochondria assay; Bid cleavage in vitro; Bcl-2/Bcl-xL epistasis; substrate specificity panel","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with purified proteins and isolated organelles, multiple substrates and epistasis tested","pmids":["11832478"],"is_preprint":false},{"year":2002,"finding":"Caspase-2 acts upstream of mitochondria in etoposide-induced apoptosis: inhibition of CASP2 (by z-VDVAD-fmk or antisense) blocks cytochrome c release and downstream caspase-9/-3 activation; the nuclear pool of pro-caspase-2 is critical for this process.","method":"Irreversible caspase-2 inhibitor; antisense stable transfection; cell-free reconstituted system; cytochrome c release assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — pharmacological plus genetic inhibition with cell-free reconstitution, multiple readouts","pmids":["12065594"],"is_preprint":false},{"year":2004,"finding":"Caspase-2 is activated within a large multiprotein complex called the PIDDosome, composed of PIDD (a p53-inducible death-domain protein) and the adaptor RAIDD; increased PIDD expression causes spontaneous caspase-2 activation and sensitizes cells to genotoxic stimuli.","method":"Co-immunoprecipitation of native complex; overexpression and knockdown; caspase-2 activity assays; genotoxic stress paradigm","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — complex purification with activity assays, replicated and cited >500 times","pmids":["15073321"],"is_preprint":false},{"year":2005,"finding":"PIDD plays distinct roles depending on complex composition: a PIDD–RAIDD–caspase-2 complex mediates apoptosis, while a separate PIDD–RIP1–NEMO complex activates NF-κB upon genotoxic stress; depletion of PIDD and RIP1 (but not caspase-2) abrogates DNA-damage-induced NEMO modification and NF-κB activation, demonstrating CASP2-independent PIDDosome signaling.","method":"RNAi knockdown; co-immunoprecipitation; NF-κB reporter assays; NEMO sumoylation/ubiquitination assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — epistasis with RNAi in multiple conditions, orthogonal readouts, 284 citations","pmids":["16360037"],"is_preprint":false},{"year":2012,"finding":"During sustained ER stress, IRE1α RNase cleaves microRNA precursors (miR-17, -34a, -96, -125b) that normally repress CASP2 mRNA translation, causing derepression of CASP2 protein expression and initiating the mitochondrial apoptotic pathway; recombinant IRE1α cleaves miRNA precursors at sites distinct from DICER.","method":"Cell-free IRE1α cleavage of miRNA precursors; ribosome profiling/translation assays; CASP2 protein quantification upon ER stress; epistasis with miRNA mimics/inhibitors","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro cleavage by recombinant IRE1α plus cellular epistasis, 550 citations","pmids":["23042294"],"is_preprint":false},{"year":2014,"finding":"CASP2 is an endogenous repressor of autophagy; knockout or knockdown of CASP2 upregulates autophagy via AMPK–mTOR and AMPK–MAPK canonical pathways, and reinsertion of Casp2 in casp2−/− MEFs suppresses autophagy; enhanced ROS production downstream of CASP2 loss is an upstream event in autophagy induction.","method":"Casp2 knockout MEFs; Casp2 re-expression rescue; autophagy marker assays (LC3, p62); pathway inhibitors; ROS measurement","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — KO plus genetic rescue, multiple pathway inhibitors and orthogonal readouts","pmids":["24879153"],"is_preprint":false},{"year":2014,"finding":"Combined suppression of CASP2 (siRNA) and CASP6 (dominant-negative mutant) promotes retinal ganglion cell axon regeneration via activation of astrocytes and Müller cells, increased CNTF production, and JAK/STAT signaling; this regeneration is abrogated by CNTF receptor blockade or JAK/STAT inhibition.","method":"siRNA knockdown of CASP2; dominant-negative CASP6; optic nerve crush model; neutralizing antibody and kinase inhibitor epistasis; GFAP and CNTF immunostaining","journal":"Brain","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro models with pathway epistasis, but combined manipulation makes CASP2-specific contribution partially indirect","pmids":["24727569"],"is_preprint":false},{"year":2017,"finding":"Rabies virus phosphoprotein binds BECN1, reducing CASP2 levels and activating CASP2-AMPK-AKT-mTOR and CASP2-AMPK-MAPK pathways, thereby inducing incomplete autophagy (autophagosome accumulation with impaired flux).","method":"Co-immunoprecipitation of BECN1 with viral P protein; CASP2 knockdown/overexpression; autophagy flux assays; AMPK/mTOR/MAPK pathway inhibitors","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and pathway epistasis, single lab","pmids":["28129024"],"is_preprint":false},{"year":2023,"finding":"Biallelic truncating variants in CASP2 cause a neurodevelopmental disorder with anterior-predominant lissencephaly and pachygyria, establishing CASP2 as an essential component of the PIDDosome required for normal cerebral cortex development; the phenotype resembles CRADD- and PIDD1-related disorders.","method":"Exome sequencing; RNA splicing studies of splice-site variant; clinical and neuroimaging phenotyping across 7 patients from 5 families","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — human genetic evidence with RNA validation, multiple independent families, but no in vitro functional reconstitution","pmids":["37880421"],"is_preprint":false},{"year":2024,"finding":"CCN1 upregulates CASP2 transcription via an RB1/E2F1 mechanism (by downregulating p16 and p21 to increase RB1 phosphorylation) but simultaneously upregulates HuR which binds CASP2 mRNA and blocks its translation, so CASP2 protein does not increase and does not contribute to CCN1-induced apoptosis in esophageal adenocarcinoma cells.","method":"Reporter assays; western blot; RNAi knockdown of RB1, E2F1, HuR; RNA immunoprecipitation for HuR-CASP2 mRNA binding; CASP2 overexpression rescue","journal":"Journal of cell communication and signaling","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal molecular approaches, single lab","pmids":["39524140"],"is_preprint":false}],"current_model":"CASP2 (caspase-2) is an initiator cysteine protease that is synthesized as an inactive zymogen, undergoes prodomain-dependent nuclear/Golgi localization, and is activated by CARD-mediated recruitment into the PIDDosome complex (PIDD–RAIDD–CASP2) upon genotoxic or ER stress; once active, it acts upstream of mitochondria to cleave Bid and directly permeabilize mitochondria causing cytochrome c, AIF, and Smac release, thereby initiating the caspase-9/caspase-3 amplification cascade, and it also cleaves the Golgi substrate golgin-160; its translation is post-transcriptionally regulated by IRE1α-mediated decay of repressive microRNAs, and it serves as an endogenous repressor of autophagy through the AMPK–mTOR and AMPK–MAPK pathways."},"narrative":{"teleology":[{"year":1994,"claim":"The initial identification of CASP2 (ICH-1/Nedd2) established it as a caspase family member capable of promoting apoptosis, with an alternatively spliced short isoform acting as a dominant-negative suppressor—resolving the question of whether a second mammalian ICE homolog participates in cell death.","evidence":"Overexpression of long and short isoforms in mammalian cells with serum deprivation and BCL-2 epistasis assays","pmids":["8087842","7958843"],"confidence":"High","gaps":["Endogenous substrates unknown","Mechanism of activation not addressed","Relationship to mitochondrial pathway uncharacterized"]},{"year":1997,"claim":"Discovery of the RAIDD/CRADD adaptor answered how CASP2 is recruited to upstream death signaling: RAIDD bridges CASP2 (via CARD–CARD interaction) and RIP (via death domain), establishing the first model for a CASP2 activation platform.","evidence":"Yeast two-hybrid, reciprocal co-immunoprecipitation, and domain deletion mapping","pmids":["8985253","9044836"],"confidence":"High","gaps":["Identity of the upstream trigger that engages RAIDD was unknown","Stoichiometry and structure of activation complex unresolved","Whether RAIDD is required in vivo not tested"]},{"year":1998,"claim":"Structural and cell-biological studies resolved two key mechanistic questions: (1) the NMR structure of the RAIDD CARD revealed complementary charged surfaces mediating CARD–CARD interaction with CASP2, and (2) the CASP2 prodomain was shown to direct nuclear localization and to promote zymogen dimerization prior to autoprocessing.","evidence":"NMR structure with mutagenesis; GFP-prodomain fusions and subcellular fractionation; yeast dimerization assay with processing-deficient mutants","pmids":["9695946","9733748","9506977"],"confidence":"High","gaps":["Nuclear function of caspase-2 versus cytoplasmic function not distinguished","Structure of full-length CASP2 or its complex with RAIDD not solved","Signal connecting nuclear CASP2 to mitochondrial permeabilization unknown"]},{"year":2000,"claim":"Identification of golgin-160 as a Golgi-localized caspase-2-specific substrate revealed a non-nuclear function and explained how CASP2 contributes to Golgi fragmentation during apoptosis.","evidence":"Subcellular fractionation, immunofluorescence, in vitro cleavage assays, and cleavage-site mutagenesis","pmids":["10791974"],"confidence":"High","gaps":["Whether Golgi cleavage is required for cell death or is a bystander event","Full substrate repertoire at the Golgi not mapped"]},{"year":2002,"claim":"Three convergent studies placed CASP2 unambiguously upstream of mitochondria: active caspase-2 directly permeabilizes isolated mitochondria (releasing cytochrome c, AIF, Smac) and cleaves Bid, while pharmacological or genetic inhibition of CASP2 blocks cytochrome c release and downstream caspase-9/caspase-3 activation.","evidence":"Purified recombinant caspase-2 on isolated mitochondria; z-VDVAD-fmk and antisense; cell-free reconstitution; Bcl-2/Bcl-xL epistasis","pmids":["12193789","11832478","12065594"],"confidence":"High","gaps":["Whether CASP2 directly forms pores in mitochondrial membranes or requires Bax/Bak was unresolved","Relative contributions of Bid cleavage versus direct permeabilization unclear"]},{"year":2004,"claim":"Identification of the PIDDosome (PIDD–RAIDD–CASP2) as the physiological activation platform for caspase-2 answered how genotoxic stress triggers CASP2 activation: the p53-inducible protein PIDD scaffolds complex assembly.","evidence":"Native complex immunoprecipitation; PIDD overexpression and knockdown; caspase-2 activity assays under genotoxic stress","pmids":["15073321"],"confidence":"High","gaps":["Whether the PIDDosome is the sole activation mechanism for CASP2 or context-dependent","Structural basis of the tripartite complex unknown at the time"]},{"year":2005,"claim":"The finding that PIDD forms a separate PIDD–RIP1–NEMO complex that activates NF-κB independently of caspase-2 showed that the PIDDosome is a bifunctional signaling hub, and CASP2 is required only for its apoptotic output.","evidence":"RNAi of PIDD, RIP1, and CASP2; NF-κB reporter assays; NEMO modification analysis","pmids":["16360037"],"confidence":"High","gaps":["How the cell chooses between apoptotic and NF-κB-activating PIDDosome assemblies is unknown","Post-translational signals governing complex switching not identified"]},{"year":2012,"claim":"The discovery that IRE1α RNase degrades miRNA precursors (miR-17, -34a, -96, -125b) that repress CASP2 translation during ER stress answered how CASP2 protein levels are acutely upregulated to commit cells to apoptosis under prolonged UPR signaling.","evidence":"Cell-free IRE1α cleavage of miRNA precursors; ribosome profiling; CASP2 protein quantification; miRNA mimic/inhibitor epistasis","pmids":["23042294"],"confidence":"High","gaps":["Whether additional post-transcriptional regulators cooperate with IRE1α-mediated derepression","Quantitative threshold of CASP2 protein needed for apoptosis commitment not defined"]},{"year":2014,"claim":"Genetic knockout and rescue experiments established an unexpected non-apoptotic role for CASP2 as an endogenous suppressor of autophagy via AMPK–mTOR and AMPK–MAPK pathways, expanding its function beyond cell death.","evidence":"Casp2 KO MEFs with re-expression rescue; LC3/p62 autophagy flux assays; AMPK/mTOR pathway inhibitors; ROS measurement","pmids":["24879153"],"confidence":"High","gaps":["Whether CASP2 directly cleaves an AMPK pathway component or acts indirectly through ROS","In vivo physiological contexts in which CASP2-regulated autophagy is relevant remain unclear"]},{"year":2023,"claim":"Human genetic evidence linked biallelic CASP2 loss-of-function to a neurodevelopmental lissencephaly–pachygyria syndrome, establishing CASP2 as essential for cortical development and phenocopying CRADD and PIDD1 deficiency.","evidence":"Exome sequencing of 7 patients from 5 families; RNA splicing validation of a splice-site variant; neuroimaging","pmids":["37880421"],"confidence":"Medium","gaps":["No in vitro functional reconstitution of the truncating variants","Mechanism by which PIDDosome dysfunction causes lissencephaly (apoptotic vs. non-apoptotic) unknown","Animal model recapitulation not demonstrated"]},{"year":null,"claim":"Key unresolved questions include the complete substrate repertoire of caspase-2, the structural basis of the full PIDDosome assembly, the mechanism by which CASP2 directly permeabilizes mitochondrial membranes, and how its apoptotic versus autophagy-suppressive functions are coordinated in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["Full substrate spectrum not systematically mapped","Cryo-EM or crystal structure of intact PIDDosome with CASP2 absent","Whether CASP2-mediated autophagy suppression is relevant to the lissencephaly phenotype is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,4,14,16]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,4,14,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,17]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[14]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,6,15,16,17,18]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[21,23]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[20]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[24]}],"complexes":["PIDDosome (PIDD–RAIDD–CASP2)"],"partners":["CRADD","PIDD1","BID","GOLGA3","ARC","RIPK1"],"other_free_text":[]},"mechanistic_narrative":"Caspase-2 is an initiator cysteine protease that couples diverse cellular stresses—including genotoxic damage, trophic factor withdrawal, and sustained ER stress—to the mitochondrial apoptotic pathway. It is synthesized as an inactive zymogen whose CARD-containing prodomain directs nuclear and Golgi localization, and is activated by CARD–CARD-mediated recruitment into the PIDDosome complex (PIDD–RAIDD–CASP2), where proximity-induced dimerization precedes autoprocessing [PMID:15073321, PMID:9695946, PMID:9506977]. Once active, caspase-2 acts upstream of mitochondria to cleave Bid and directly permeabilize the outer mitochondrial membrane, releasing cytochrome c, AIF, and Smac to engage the caspase-9/caspase-3 amplification cascade; it also cleaves golgin-160 to promote Golgi disassembly during apoptosis [PMID:11832478, PMID:10791974, PMID:12193789]. Beyond apoptosis, CASP2 functions as an endogenous repressor of autophagy through the AMPK–mTOR and AMPK–MAPK axes [PMID:24879153], and biallelic loss-of-function variants in CASP2 cause a neurodevelopmental lissencephaly–pachygyria syndrome linked to PIDDosome dysfunction [PMID:37880421]."},"prefetch_data":{"uniprot":{"accession":"P42575","full_name":"Caspase-2","aliases":["Neural precursor cell expressed developmentally down-regulated protein 2","NEDD-2","Protease ICH-1"],"length_aa":452,"mass_kda":50.7,"function":"Is a regulator of the cascade of caspases responsible for apoptosis execution (PubMed:11156409, PubMed:15073321, PubMed:8087842). Might function by either activating some proteins required for cell death or inactivating proteins necessary for cell survival (PubMed:15073321). Associates with PIDD1 and CRADD to form the PIDDosome, a complex that activates CASP2 and triggers apoptosis in response to genotoxic stress (PubMed:15073321) Acts as a positive regulator of apoptosis Acts as a negative regulator of apoptosis May function as an endogenous apoptosis inhibitor that antagonizes caspase activation and cell death","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P42575/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CASP2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000106144","cell_line_id":"CID001705","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"PDS5B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001705","total_profiled":1310},"omim":[{"mim_id":"620653","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 80, WITH VARIANT LISSENCEPHALY; MRT80","url":"https://www.omim.org/entry/620653"},{"mim_id":"619827","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75","url":"https://www.omim.org/entry/619827"},{"mim_id":"616466","title":"UNC5 NETRIN RECEPTOR D; UNC5D","url":"https://www.omim.org/entry/616466"},{"mim_id":"614499","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34","url":"https://www.omim.org/entry/614499"},{"mim_id":"610934","title":"NOBOX OOGENESIS HOMEOBOX; NOBOX","url":"https://www.omim.org/entry/610934"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CASP2"},"hgnc":{"alias_symbol":["ICH1","PPP1R57","MGC2181"],"prev_symbol":["NEDD2"]},"alphafold":{"accession":"P42575","domains":[{"cath_id":"1.10.533.10","chopping":"33-125","consensus_level":"high","plddt":88.3939,"start":33,"end":125},{"cath_id":"3.40.50.1460","chopping":"180-325_359-437","consensus_level":"high","plddt":93.3777,"start":180,"end":437}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P42575","model_url":"https://alphafold.ebi.ac.uk/files/AF-P42575-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P42575-F1-predicted_aligned_error_v6.png","plddt_mean":78.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CASP2","jax_strain_url":"https://www.jax.org/strain/search?query=CASP2"},"sequence":{"accession":"P42575","fasta_url":"https://rest.uniprot.org/uniprotkb/P42575.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P42575/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P42575"}},"corpus_meta":[{"pmid":"8087842","id":"PMC_8087842","title":"Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8087842","citation_count":822,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7958843","id":"PMC_7958843","title":"Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7958843","citation_count":600,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9507158","id":"PMC_9507158","title":"Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.","date":"1998","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9507158","citation_count":226,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7642516","id":"PMC_7642516","title":"Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642516","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9045720","id":"PMC_9045720","title":"Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9045720","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9733748","id":"PMC_9733748","title":"Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9733748","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9148927","id":"PMC_9148927","title":"Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9148927","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16166278","id":"PMC_16166278","title":"T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16166278","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9506977","id":"PMC_9506977","title":"Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9506977","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9801360","id":"PMC_9801360","title":"Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9801360","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485512","id":"PMC_9485512","title":"Evaluation of the CASP2 docking section.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485512","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24879153","id":"PMC_24879153","title":"A nonapoptotic role for CASP2/caspase 2: modulation of autophagy.","date":"2014","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24879153","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24727569","id":"PMC_24727569","title":"Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.","date":"2014","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24727569","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9078393","id":"PMC_9078393","title":"Processing of the Nedd2 precursor by ICE-like proteases and granzyme B.","date":"1996","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/9078393","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9326271","id":"PMC_9326271","title":"Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support.","date":"1997","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9326271","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7615091","id":"PMC_7615091","title":"Inhibition of apoptosis by the expression of antisense Nedd2.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7615091","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28129024","id":"PMC_28129024","title":"BECN1-dependent CASP2 incomplete autophagy induction by binding to rabies virus phosphoprotein.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28129024","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9183288","id":"PMC_9183288","title":"Up-regulation of the Nedd2 gene encoding an ICE/Ced-3-like cysteine protease in the gerbil brain after transient global ischemia.","date":"1997","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9183288","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10964483","id":"PMC_10964483","title":"Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32).","date":"2000","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10964483","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35436510","id":"PMC_35436510","title":"miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2.","date":"2022","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/35436510","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9671586","id":"PMC_9671586","title":"The ich1 gene of the mushroom Coprinus cinereus is essential for pileus formation in fruiting.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9671586","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9135979","id":"PMC_9135979","title":"Meeting review: the Second meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, December 13-16, 1996.","date":"1997","source":"Folding & design","url":"https://pubmed.ncbi.nlm.nih.gov/9135979","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485507","id":"PMC_9485507","title":"CASP2: report on ab initio predictions.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485507","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7789948","id":"PMC_7789948","title":"Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms.","date":"1995","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7789948","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485516","id":"PMC_9485516","title":"CASP2 experiences with docking flexible ligands using FlexX.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485516","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28783714","id":"PMC_28783714","title":"Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13.","date":"2017","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/28783714","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30816202","id":"PMC_30816202","title":"MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30816202","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8780721","id":"PMC_8780721","title":"Chromosomal localization of the human genes, CPP32, Mch2, Mch3, and Ich-1, involved in cellular apoptosis.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8780721","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485499","id":"PMC_9485499","title":"A retrospective analysis of CASP2 threading predictions.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485499","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11835484","id":"PMC_11835484","title":"CASP2 knowledge-based approach to distant homology recognition and fold prediction in CASP4.","date":"2001","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/11835484","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9224894","id":"PMC_9224894","title":"Characterization of the avian Ich-1 cDNA and expression of Ich-1L mRNA in the hen ovary.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9224894","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9269827","id":"PMC_9269827","title":"Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts.","date":"1997","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9269827","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11073159","id":"PMC_11073159","title":"Reactivation of Nedd-2, a developmentally down-regulated apoptotic gene, in apoptosis induced by a street strain of rabies virus.","date":"2000","source":"Journal of medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11073159","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485508","id":"PMC_9485508","title":"Blind predictions of local protein structure in CASP2 targets using the I-sites library.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485508","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485514","id":"PMC_9485514","title":"CASP2 molecular docking predictions with the LIGIN software.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485514","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9485502","id":"PMC_9485502","title":"Fold assignments for amino acid sequences of the CASP2 experiment.","date":"1997","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/9485502","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9809666","id":"PMC_9809666","title":"Expression of Nedd2/ICH-1 (caspase-2) in the developing rat retina.","date":"1998","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9809666","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37880421","id":"PMC_37880421","title":"Bi-allelic truncating variants in CASP2 underlie a neurodevelopmental disorder with lissencephaly.","date":"2023","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/37880421","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9209399","id":"PMC_9209399","title":"Characterization of a mammalian cell death gene Nedd2.","date":"1997","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/9209399","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35085690","id":"PMC_35085690","title":"MiR-17-5p protects neonatal mice from hypoxic-ischemic brain damage by targeting Casp2.","date":"2022","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/35085690","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38509889","id":"PMC_38509889","title":"PANoptosis-related molecule CASP2 affects the immune microenvironment and immunotherapy response of hepatocellular carcinoma.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38509889","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39524140","id":"PMC_39524140","title":"Cellular communication network 1 promotes CASP2 mRNA expression but suppresses its protein translation in esophageal adenocarcinoma.","date":"2024","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/39524140","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12297434","id":"PMC_12297434","title":"[Relationship between hepatitis C virus infection and expression of apoptosis-related gene bcl-2, bax and ICH-1 in hepatocellular carcinoma tissues].","date":"2002","source":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","url":"https://pubmed.ncbi.nlm.nih.gov/12297434","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10329646","id":"PMC_10329646","title":"Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10329646","citation_count":621,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12193789","id":"PMC_12193789","title":"Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12193789","citation_count":592,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23042294","id":"PMC_23042294","title":"IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23042294","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15073321","id":"PMC_15073321","title":"The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress.","date":"2004","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15073321","citation_count":531,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8044845","id":"PMC_8044845","title":"Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8044845","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8962078","id":"PMC_8962078","title":"Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8962078","citation_count":489,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18723680","id":"PMC_18723680","title":"Executioner caspase-3 and caspase-7 are functionally distinct proteases.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18723680","citation_count":459,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8985253","id":"PMC_8985253","title":"RAIDD is a new 'death' adaptor molecule.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8985253","citation_count":455,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11832478","id":"PMC_11832478","title":"Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11832478","citation_count":427,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26871637","id":"PMC_26871637","title":"Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26871637","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12065594","id":"PMC_12065594","title":"Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12065594","citation_count":334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10791974","id":"PMC_10791974","title":"Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10791974","citation_count":320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9560245","id":"PMC_9560245","title":"ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9560245","citation_count":301,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9228018","id":"PMC_9228018","title":"FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9228018","citation_count":287,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16360037","id":"PMC_16360037","title":"PIDD mediates NF-kappaB activation in response to DNA damage.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16360037","citation_count":284,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9695946","id":"PMC_9695946","title":"Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9695946","citation_count":272,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9044836","id":"PMC_9044836","title":"CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9044836","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18758,"output_tokens":2933,"usd":0.050134},"stage2":{"model":"claude-opus-4-6","input_tokens":6294,"output_tokens":2339,"usd":0.134917},"total_usd":0.460587,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":30626,"output_tokens":5797,"usd":0.089416},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9726,"output_tokens":3018,"usd":0.18612}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"CASP2 (Ich-1/ICH-1L) encodes a cysteine protease whose overexpression induces programmed cell death, while an alternatively spliced truncated form (ICH-1S) suppresses serum-deprivation-induced cell death, demonstrating that alternative splicing produces both positive and negative regulators of apoptosis.\",\n      \"method\": \"Overexpression in mammalian cells, alternative splicing analysis, cell death assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational study, replicated across multiple cell-based experiments with orthogonal readouts, >800 citations\",\n      \"pmids\": [\"8087842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CASP2 (Nedd2) overexpression induces apoptosis in fibroblast and neuroblastoma cells, and this cell death is suppressed by BCL-2, placing CASP2 in a BCL-2-regulated apoptotic pathway.\",\n      \"method\": \"Overexpression in cultured cells, BCL-2 co-expression rescue, morphological apoptosis assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (BCL-2 suppression), replicated findings, >600 citations\",\n      \"pmids\": [\"7958843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CASP2 (Nedd2) cleaves poly(ADP-ribose) polymerase (PARP) in a manner identical to that observed in apoptotic cells when co-expressed with PARP in COS cells, and purified recombinant ICE cleaves PARP in vitro in a time- and concentration-dependent manner.\",\n      \"method\": \"COS cell co-transfection assay, in vitro cleavage assay with purified recombinant protein\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified enzyme plus cell-based validation\",\n      \"pmids\": [\"7642516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Antisense suppression of CASP2 (Nedd2) in factor-dependent FDC-P1 cells inhibits apoptosis upon cytokine withdrawal, demonstrating a direct functional requirement for CASP2 in cytokine deprivation-induced apoptosis.\",\n      \"method\": \"Antisense RNA expression, cell death assay upon cytokine withdrawal\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined phenotypic readout, single lab\",\n      \"pmids\": [\"7615091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The pro-CASP2 (pro-Nedd2) precursor is cleaved into p19 and p12 subunits by ICE-like proteases (CPP32/caspase-3, ICE, Mch2) and by granzyme B in vitro, indicating CASP2 activation requires upstream ICE-like protease activity and placing CASP2 as a downstream effector in CTL-mediated killing.\",\n      \"method\": \"In vitro cleavage assay with purified recombinant proteases and cell extracts, apoptotic cell extract processing assay\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple purified proteases and inhibitor validation\",\n      \"pmids\": [\"9078393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CASP2 (Nedd2) is required for apoptosis induced by trophic factor withdrawal from PC12 cells and sympathetic neurons, but not for apoptosis induced by SOD1 downregulation, demonstrating stimulus-specific roles for distinct caspases in neuronal death.\",\n      \"method\": \"Antisense oligonucleotide knockdown, cell death assay, Western blotting for protein levels, immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific loss-of-function with defined phenotype, stimulus-specificity established with orthogonal readouts\",\n      \"pmids\": [\"9045720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CASP2 (Nedd2/ICH-1) is activated very early during apoptosis, preceding activation of CPP32 (caspase-3), suggesting CASP2 acts upstream in the caspase cascade as an early effector.\",\n      \"method\": \"Western blotting for processed subunits, multiple apoptotic stimuli, temporal activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical detection of processing, multiple stimuli, single lab\",\n      \"pmids\": [\"9148927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The CASP2 (Nedd2) precursor undergoes dimerization prior to processing; dimerization requires both the prodomain and the carboxyl-terminal residues. In vitro processing by recombinant active Nedd2 defined the aspartate residues critical for cleavage.\",\n      \"method\": \"Yeast two-hybrid/dimerization in Saccharomyces cerevisiae, catalytically inactive and aspartate mutants, in vitro processing with recombinant enzyme, cell death assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, combined with in vivo yeast dimerization assay\",\n      \"pmids\": [\"9506977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The prodomain of CASP2 (Nedd2) is required for nuclear localization; GFP fusions show prodomain-containing CASP2 localizes to dot- and fiber-like structures in the nucleus, and the CASP2 prodomain can redirect caspase-3 (normally cytoplasmic) to the nucleus.\",\n      \"method\": \"GFP fusion constructs, live-cell fluorescence imaging, domain deletion and swap experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with GFP fusions, domain-swap functional validation, multiple constructs tested\",\n      \"pmids\": [\"9733748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CASP2 (caspase-2/Nedd-2) processing at D333 and cell death in trophic-factor-deprived PC12 cells and sympathetic neurons occurs independently of caspase-3-like activity; antisense to caspase-2 inhibits death without affecting caspase-3-like activity, placing CASP2 in a parallel pathway to caspase-3.\",\n      \"method\": \"Antisense oligonucleotide knockdown, caspase activity assays (DEVD-FMK inhibition), Western blotting for processed products, genetic epistasis with BCL-2 and flavopiridol\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple agents, loss-of-function, orthogonal inhibitor approaches\",\n      \"pmids\": [\"9801360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CASP2 functions as an endogenous repressor of autophagy; knockout or knockdown of CASP2 upregulates autophagy via AMPK, mTOR, and MAPK pathways, and reintroduction of Casp2 in casp2-/- MEFs suppresses autophagy, identifying a non-apoptotic role for CASP2.\",\n      \"method\": \"Casp2 knockout MEFs, siRNA knockdown, Casp2 gene reintroduction rescue, autophagy marker assays (LC3, p62), pathway inhibitor studies\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with rescue, multiple cell types, pathway dissection with inhibitors, single lab\",\n      \"pmids\": [\"24879153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Biallelic truncating variants in CASP2 cause a neurodevelopmental disorder with lissencephaly and pachygyria, demonstrating that CASP2 as part of the PIDDosome complex is critical for normal human cortical development.\",\n      \"method\": \"Exome sequencing, RNA splicing studies of splice-site variant, genetic segregation analysis in five families\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetic loss-of-function with RNA functional validation, multiple families, phenotypic parallel to CRADD/PIDD1 disorders\",\n      \"pmids\": [\"37880421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CCN1 upregulates CASP2 mRNA transcription via E2F1 (through RB1 phosphorylation after p16/p21 downregulation) but simultaneously upregulates HuR, which binds CASP2 mRNA and blocks its protein translation, revealing a post-transcriptional regulatory mechanism suppressing CASP2 protein levels.\",\n      \"method\": \"mRNA and protein expression analyses, RB1/E2F1 pathway manipulation, HuR binding to CASP2 mRNA, cell apoptosis assays\",\n      \"journal\": \"Journal of cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of transcriptional and translational regulation with pathway manipulation, single lab\",\n      \"pmids\": [\"39524140\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CASP2 is an initiator caspase (cysteine protease) that, upon dimerization mediated by its prodomain and C-terminal region, undergoes autoprocessing or trans-processing by upstream ICE-family proteases (including granzyme B) to generate active p19/p12 subunits; its prodomain also directs nuclear localization, it acts early in the apoptotic cascade upstream of or in parallel with caspase-3, is required for trophic-factor-withdrawal-induced neuronal apoptosis, functions non-apoptotically as an endogenous repressor of autophagy via AMPK/mTOR/MAPK pathways, and is an essential component of the PIDDosome complex required for normal cortical development.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"ICH-1L (the long form of CASP2) induces programmed cell death when overexpressed, while the alternatively spliced short form ICH-1S suppresses serum deprivation-induced cell death, demonstrating that CASP2 encodes both positive and negative regulators of apoptosis via alternative splicing.\",\n      \"method\": \"Overexpression in mammalian cells; serum deprivation apoptosis assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original functional characterization replicated across constructs, foundational paper with 822 citations\",\n      \"pmids\": [\"8087842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Nedd2/CASP2 overexpression induces apoptosis in fibroblast and neuroblastoma cells, and this death is suppressed by BCL-2, placing CASP2 downstream of BCL-2 in the programmed cell death pathway.\",\n      \"method\": \"Overexpression and genetic epistasis in cultured cells; BCL-2 co-expression rescue\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with BCL-2, replicated by multiple labs, 600 citations\",\n      \"pmids\": [\"7958843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CASP2/Nedd2, together with ICE (CASP1), cleaves PARP in a manner identical to apoptotic cleavage; in vitro, recombinant ICE cleaves PARP in a time- and enzyme-concentration-dependent manner, though requiring 50–100-fold higher concentration than for IL-1β processing.\",\n      \"method\": \"COS cell co-transfection assay; in vitro cleavage with purified recombinant enzyme\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified enzyme plus cellular co-expression assay\",\n      \"pmids\": [\"7642516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Antisense suppression of Nedd2/CASP2 in FDC-P1 cells significantly inhibits apoptosis upon cytokine withdrawal, demonstrating a direct role for CASP2 in mediating apoptosis.\",\n      \"method\": \"Antisense Nedd2 expression; cell death assay upon cytokine removal\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"7615091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The pro-Nedd2/CASP2 precursor (p51) is processed in vitro by CPP32 (caspase-3), ICE, and granzyme B into p19 and p12 subunits, indicating that CASP2 activation requires cleavage by upstream ICE-like proteases and that CASP2 may be a downstream effector in CTL-mediated killing.\",\n      \"method\": \"In vitro processing assay with purified caspases and granzyme B; cell extract processing assays\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro cleavage with purified enzymes, multiple proteases tested\",\n      \"pmids\": [\"9078393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CASP2/Nedd2 is activated early during apoptosis induced by diverse stimuli, preceding caspase-3 (CPP32) activation, consistent with CASP2 being an upstream initiator caspase.\",\n      \"method\": \"Western blot detection of processed CASP2 in cells treated with apoptotic agents; temporal comparison with caspase-3 activation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — temporal ordering with multiple stimuli, single lab\",\n      \"pmids\": [\"9148927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Nedd2/CASP2 is required for apoptosis induced by trophic factor withdrawal in PC12 cells and sympathetic neurons, but not for apoptosis caused by SOD1 downregulation, demonstrating stimulus-specific roles for distinct caspases.\",\n      \"method\": \"Antisense oligonucleotide knockdown; cell death and immunohistochemical assays in neurons and PC12 cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific phenotypic readouts and stimulus specificity, replicated across cell types\",\n      \"pmids\": [\"9045720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RAIDD (CRADD) is an adaptor molecule that directly binds to caspase-2 via homophilic CARD–CARD (prodomain) interaction, and also binds to the death domain-containing kinase RIP, linking CASP2 to upstream death signaling pathways.\",\n      \"method\": \"Yeast two-hybrid and immunoprecipitation; domain mapping\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding confirmed with domain mapping, 455 citations, replicated\",\n      \"pmids\": [\"8985253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CRADD contains an N-terminal caspase homology domain that specifically interacts with caspase-2, and a C-terminal death domain that interacts with RIP, establishing CRADD as a bipartite adaptor bridging RIP and CASP2 in apoptotic signaling.\",\n      \"method\": \"Co-immunoprecipitation; domain deletion analysis; apoptosis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with domain mapping, independently corroborated by Duan & Dixit\",\n      \"pmids\": [\"9044836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The RAIDD CARD structure was solved by NMR and shown to consist of six helices arranged in a death-domain topology; mutagenesis of basic and acidic surface patches on opposite sides of RAIDD CARD and ICH-1/CASP2 CARD mediate their homophilic CARD–CARD interaction.\",\n      \"method\": \"NMR structure determination; mutagenesis; homology modeling\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure plus mutagenesis with functional validation\",\n      \"pmids\": [\"9695946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The pro-Nedd2/CASP2 precursor dimerizes prior to autoprocessing; both the prodomain and C-terminal residues are required for dimerization, and dimerization occurs before cleavage of the catalytic subunits as shown in yeast.\",\n      \"method\": \"Yeast-based dimerization assay; aspartate-to-alanine mutants; in vitro processing by recombinant active Nedd2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in yeast plus in vitro processing, mutagenesis of critical aspartates\",\n      \"pmids\": [\"9506977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The prodomain of CASP2 is required for nuclear localization of the precursor; GFP-fused prodomain alone localizes to nuclear dot- and fiber-like structures, and fusing the CASP2 prodomain to the normally cytoplasmic caspase-3 mediates its nuclear transport.\",\n      \"method\": \"GFP fusion constructs; live fluorescence microscopy; subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging with functional domain swaps, clear mechanistic conclusion\",\n      \"pmids\": [\"9733748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CASP2 processing at D333 occurs independently of caspase-3-like activity during trophic factor withdrawal; caspase-2 is required for death but caspase-3-like activity is neither necessary nor sufficient, placing CASP2 in a parallel or independent branch from caspase-3.\",\n      \"method\": \"Western blot for CASP2 processing; selective caspase inhibitors (DEVD-FMK vs BAF/zVAD); antisense to CASP2; enzymatic activity assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pharmacological and genetic approaches, clear epistasis\",\n      \"pmids\": [\"9801360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ARC (apoptosis repressor with CARD) interacts selectively with caspase-2 (and caspase-8, CED-3) but not caspase-1, -3, or -9, via CARD–CARD interaction, and inhibits caspase-2-induced apoptosis; ARC is expressed primarily in skeletal muscle and heart.\",\n      \"method\": \"Immunoprecipitation; co-transfection apoptosis assays; enzymatic inhibition assay in 293T cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with selectivity controls, functional inhibition assay\",\n      \"pmids\": [\"9560245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Caspase-2 localizes to the Golgi complex (in addition to nucleus) and cleaves golgin-160 at a unique site not cleaved by other caspases with similar peptide specificities; prevention of this cleavage delays Golgi disintegration during apoptosis.\",\n      \"method\": \"Subcellular fractionation; immunofluorescence microscopy; in vitro cleavage assays; mutagenesis of golgin-160 cleavage site; apoptotic morphology assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (localization, in vitro cleavage, mutagenesis, functional rescue), rigorous controls\",\n      \"pmids\": [\"10791974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Caspase-2 is required upstream of mitochondria for cytotoxic stress-induced apoptosis; it is activated before mitochondrial permeabilization and is necessary for cytochrome c release, establishing CASP2 as an initiator that acts upstream of the mitochondrial amplification step.\",\n      \"method\": \"Caspase-2 inhibitors and dominant-negative constructs; cytochrome c release assay; epistasis with mitochondrial pathway\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological epistasis, replicated independently (Guo et al. and Robertson et al. same year), 592 citations\",\n      \"pmids\": [\"12193789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Caspase-2 induces cytochrome c, AIF, and Smac release from isolated mitochondria independently of Bid or cytosolic factors; it also cleaves cytosolic Bid, which then triggers cytochrome c release; Bcl-2 and Bcl-xL block caspase-2-induced death; unlike caspase-8, caspase-2 cannot directly process other caspase zymogens.\",\n      \"method\": \"Purified recombinant caspase-2; isolated mitochondria assay; Bid cleavage in vitro; Bcl-2/Bcl-xL epistasis; substrate specificity panel\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with purified proteins and isolated organelles, multiple substrates and epistasis tested\",\n      \"pmids\": [\"11832478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Caspase-2 acts upstream of mitochondria in etoposide-induced apoptosis: inhibition of CASP2 (by z-VDVAD-fmk or antisense) blocks cytochrome c release and downstream caspase-9/-3 activation; the nuclear pool of pro-caspase-2 is critical for this process.\",\n      \"method\": \"Irreversible caspase-2 inhibitor; antisense stable transfection; cell-free reconstituted system; cytochrome c release assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — pharmacological plus genetic inhibition with cell-free reconstitution, multiple readouts\",\n      \"pmids\": [\"12065594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Caspase-2 is activated within a large multiprotein complex called the PIDDosome, composed of PIDD (a p53-inducible death-domain protein) and the adaptor RAIDD; increased PIDD expression causes spontaneous caspase-2 activation and sensitizes cells to genotoxic stimuli.\",\n      \"method\": \"Co-immunoprecipitation of native complex; overexpression and knockdown; caspase-2 activity assays; genotoxic stress paradigm\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complex purification with activity assays, replicated and cited >500 times\",\n      \"pmids\": [\"15073321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PIDD plays distinct roles depending on complex composition: a PIDD–RAIDD–caspase-2 complex mediates apoptosis, while a separate PIDD–RIP1–NEMO complex activates NF-κB upon genotoxic stress; depletion of PIDD and RIP1 (but not caspase-2) abrogates DNA-damage-induced NEMO modification and NF-κB activation, demonstrating CASP2-independent PIDDosome signaling.\",\n      \"method\": \"RNAi knockdown; co-immunoprecipitation; NF-κB reporter assays; NEMO sumoylation/ubiquitination assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with RNAi in multiple conditions, orthogonal readouts, 284 citations\",\n      \"pmids\": [\"16360037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"During sustained ER stress, IRE1α RNase cleaves microRNA precursors (miR-17, -34a, -96, -125b) that normally repress CASP2 mRNA translation, causing derepression of CASP2 protein expression and initiating the mitochondrial apoptotic pathway; recombinant IRE1α cleaves miRNA precursors at sites distinct from DICER.\",\n      \"method\": \"Cell-free IRE1α cleavage of miRNA precursors; ribosome profiling/translation assays; CASP2 protein quantification upon ER stress; epistasis with miRNA mimics/inhibitors\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro cleavage by recombinant IRE1α plus cellular epistasis, 550 citations\",\n      \"pmids\": [\"23042294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CASP2 is an endogenous repressor of autophagy; knockout or knockdown of CASP2 upregulates autophagy via AMPK–mTOR and AMPK–MAPK canonical pathways, and reinsertion of Casp2 in casp2−/− MEFs suppresses autophagy; enhanced ROS production downstream of CASP2 loss is an upstream event in autophagy induction.\",\n      \"method\": \"Casp2 knockout MEFs; Casp2 re-expression rescue; autophagy marker assays (LC3, p62); pathway inhibitors; ROS measurement\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO plus genetic rescue, multiple pathway inhibitors and orthogonal readouts\",\n      \"pmids\": [\"24879153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Combined suppression of CASP2 (siRNA) and CASP6 (dominant-negative mutant) promotes retinal ganglion cell axon regeneration via activation of astrocytes and Müller cells, increased CNTF production, and JAK/STAT signaling; this regeneration is abrogated by CNTF receptor blockade or JAK/STAT inhibition.\",\n      \"method\": \"siRNA knockdown of CASP2; dominant-negative CASP6; optic nerve crush model; neutralizing antibody and kinase inhibitor epistasis; GFAP and CNTF immunostaining\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro models with pathway epistasis, but combined manipulation makes CASP2-specific contribution partially indirect\",\n      \"pmids\": [\"24727569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Rabies virus phosphoprotein binds BECN1, reducing CASP2 levels and activating CASP2-AMPK-AKT-mTOR and CASP2-AMPK-MAPK pathways, thereby inducing incomplete autophagy (autophagosome accumulation with impaired flux).\",\n      \"method\": \"Co-immunoprecipitation of BECN1 with viral P protein; CASP2 knockdown/overexpression; autophagy flux assays; AMPK/mTOR/MAPK pathway inhibitors\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and pathway epistasis, single lab\",\n      \"pmids\": [\"28129024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Biallelic truncating variants in CASP2 cause a neurodevelopmental disorder with anterior-predominant lissencephaly and pachygyria, establishing CASP2 as an essential component of the PIDDosome required for normal cerebral cortex development; the phenotype resembles CRADD- and PIDD1-related disorders.\",\n      \"method\": \"Exome sequencing; RNA splicing studies of splice-site variant; clinical and neuroimaging phenotyping across 7 patients from 5 families\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetic evidence with RNA validation, multiple independent families, but no in vitro functional reconstitution\",\n      \"pmids\": [\"37880421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CCN1 upregulates CASP2 transcription via an RB1/E2F1 mechanism (by downregulating p16 and p21 to increase RB1 phosphorylation) but simultaneously upregulates HuR which binds CASP2 mRNA and blocks its translation, so CASP2 protein does not increase and does not contribute to CCN1-induced apoptosis in esophageal adenocarcinoma cells.\",\n      \"method\": \"Reporter assays; western blot; RNAi knockdown of RB1, E2F1, HuR; RNA immunoprecipitation for HuR-CASP2 mRNA binding; CASP2 overexpression rescue\",\n      \"journal\": \"Journal of cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal molecular approaches, single lab\",\n      \"pmids\": [\"39524140\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CASP2 (caspase-2) is an initiator cysteine protease that is synthesized as an inactive zymogen, undergoes prodomain-dependent nuclear/Golgi localization, and is activated by CARD-mediated recruitment into the PIDDosome complex (PIDD–RAIDD–CASP2) upon genotoxic or ER stress; once active, it acts upstream of mitochondria to cleave Bid and directly permeabilize mitochondria causing cytochrome c, AIF, and Smac release, thereby initiating the caspase-9/caspase-3 amplification cascade, and it also cleaves the Golgi substrate golgin-160; its translation is post-transcriptionally regulated by IRE1α-mediated decay of repressive microRNAs, and it serves as an endogenous repressor of autophagy through the AMPK–mTOR and AMPK–MAPK pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CASP2 is an initiator caspase that functions early in the apoptotic cascade and also serves non-apoptotic roles in autophagy suppression and cortical development. The proenzyme undergoes dimerization via its prodomain and C-terminal region, followed by autoprocessing or trans-processing by upstream ICE-family proteases and granzyme B to generate active p19/p12 subunits that cleave substrates including PARP [PMID:9506977, PMID:9078393, PMID:7642516]. CASP2 is required for trophic-factor-withdrawal-induced neuronal apoptosis in a pathway parallel to caspase-3 and suppressible by BCL-2, and its prodomain directs nuclear localization to discrete subnuclear structures [PMID:9801360, PMID:9733748, PMID:7958843]. Beyond apoptosis, CASP2 represses autophagy through AMPK/mTOR/MAPK signaling, and biallelic loss-of-function variants in CASP2 cause a neurodevelopmental disorder with lissencephaly, establishing its requirement in human cortical development [PMID:24879153, PMID:37880421].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of CASP2 as a cell-death-inducing cysteine protease whose alternative splicing generates both pro-apoptotic (ICH-1L) and anti-apoptotic (ICH-1S) isoforms established the gene as a direct regulator of programmed cell death, with BCL-2 epistasis placing it in a BCL-2-regulated pathway.\",\n      \"evidence\": \"Overexpression of full-length and truncated isoforms in mammalian cells with cell death assays; BCL-2 co-expression rescue in fibroblasts and neuroblastoma cells\",\n      \"pmids\": [\"8087842\", \"7958843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates were unknown\", \"Mechanism of activation was undefined\", \"Whether ICH-1S acts as a dominant-negative in vivo was untested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that CASP2 cleaves PARP identically to apoptotic cell extracts identified a direct biochemical substrate and confirmed its protease activity, while antisense knockdown showed a functional requirement in cytokine-deprivation-induced apoptosis.\",\n      \"evidence\": \"COS cell co-transfection and in vitro cleavage with purified recombinant enzyme; antisense suppression in FDC-P1 cells upon cytokine withdrawal\",\n      \"pmids\": [\"7642516\", \"7615091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full substrate repertoire remained unknown\", \"Upstream activating protease was unidentified\", \"Antisense approach lacks genetic specificity\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Reconstitution of pro-CASP2 cleavage by ICE-family proteases (caspase-3, ICE, Mch2) and granzyme B defined the activation mechanism as upstream protease-dependent processing into p19/p12 subunits, positioning CASP2 within the caspase cascade and CTL-mediated killing.\",\n      \"evidence\": \"In vitro cleavage assays with multiple purified recombinant proteases and apoptotic cell extracts\",\n      \"pmids\": [\"9078393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether autoprocessing contributes to activation in vivo was unclear\", \"Relative contribution of each upstream protease in physiological settings was undefined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Loss-of-function studies in neurons showed CASP2 is required specifically for trophic-factor-withdrawal-induced death but not SOD1-related death, establishing stimulus-specific caspase utilization, and temporal activation studies placed CASP2 upstream of caspase-3.\",\n      \"evidence\": \"Antisense knockdown in PC12 cells and sympathetic neurons; Western blot for processed subunits across multiple apoptotic stimuli\",\n      \"pmids\": [\"9045720\", \"9148927\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CASP2 directly activates caspase-3 or acts in a parallel pathway was unresolved\", \"In vivo relevance in organismal neuronal death was untested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Three key mechanistic features were resolved: CASP2 dimerization via prodomain and C-terminal region precedes processing, the prodomain directs nuclear localization to subnuclear structures, and CASP2-dependent neuronal death operates independently of caspase-3-like activity.\",\n      \"evidence\": \"Yeast two-hybrid dimerization with domain mutants; GFP-fusion live-cell imaging and domain-swap experiments; antisense knockdown combined with DEVD-FMK inhibition and BCL-2 epistasis in PC12 cells and sympathetic neurons\",\n      \"pmids\": [\"9506977\", \"9733748\", \"9801360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear substrates of CASP2 were unidentified\", \"Structural basis for dimerization was unknown\", \"Whether nuclear localization is required for apoptotic function was not directly tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that CASP2 knockout upregulates autophagy via AMPK/mTOR/MAPK pathways, rescued by gene reintroduction, revealed a non-apoptotic function as an endogenous autophagy repressor.\",\n      \"evidence\": \"Casp2 knockout MEFs, siRNA knockdown, gene rescue, autophagy marker assays (LC3/p62), pathway inhibitor studies\",\n      \"pmids\": [\"24879153\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrate mediating autophagy suppression was not identified\", \"Whether catalytic activity is required for autophagy repression was not tested\", \"In vivo relevance of autophagy regulation was not demonstrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human genetic evidence that biallelic truncating CASP2 variants cause lissencephaly/pachygyria established CASP2 as essential for cortical development and linked it to the PIDDosome-dependent neurodevelopmental disorder spectrum alongside CRADD and PIDD1.\",\n      \"evidence\": \"Exome sequencing and RNA splicing analysis across five families with genetic segregation\",\n      \"pmids\": [\"37880421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular mechanism by which CASP2 loss disrupts neuronal migration was not defined\", \"Whether apoptotic or non-apoptotic functions of CASP2 are relevant in cortical development is unknown\", \"Animal model recapitulation of the cortical phenotype was not shown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of a post-transcriptional regulatory circuit in which CCN1 drives CASP2 transcription via E2F1 but simultaneously induces HuR to block CASP2 translation revealed how CASP2 protein levels are suppressed despite mRNA upregulation.\",\n      \"evidence\": \"mRNA/protein expression analyses, RB1/E2F1 pathway manipulation, HuR-CASP2 mRNA binding assays\",\n      \"pmids\": [\"39524140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HuR-mediated suppression operates broadly or is context-specific is unclear\", \"In vivo relevance of CCN1-CASP2 axis was not established\", \"Independent validation of HuR binding site on CASP2 mRNA is lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct nuclear substrates of CASP2, the structural basis of PIDDosome-dependent activation, and the mechanism by which CASP2 loss causes cortical malformation remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No nuclear substrate has been identified\", \"No high-resolution structure of CASP2 within the PIDDosome\", \"Catalytic versus scaffolding contributions to cortical development are undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 3, 5, 9]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"complexes\": [\"PIDDosome\"],\n    \"partners\": [\"BCL2\", \"CRADD\", \"PIDD1\", \"GZMB\", \"CASP3\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Caspase-2 is an initiator cysteine protease that couples diverse cellular stresses—including genotoxic damage, trophic factor withdrawal, and sustained ER stress—to the mitochondrial apoptotic pathway. It is synthesized as an inactive zymogen whose CARD-containing prodomain directs nuclear and Golgi localization, and is activated by CARD–CARD-mediated recruitment into the PIDDosome complex (PIDD–RAIDD–CASP2), where proximity-induced dimerization precedes autoprocessing [PMID:15073321, PMID:9695946, PMID:9506977]. Once active, caspase-2 acts upstream of mitochondria to cleave Bid and directly permeabilize the outer mitochondrial membrane, releasing cytochrome c, AIF, and Smac to engage the caspase-9/caspase-3 amplification cascade; it also cleaves golgin-160 to promote Golgi disassembly during apoptosis [PMID:11832478, PMID:10791974, PMID:12193789]. Beyond apoptosis, CASP2 functions as an endogenous repressor of autophagy through the AMPK–mTOR and AMPK–MAPK axes [PMID:24879153], and biallelic loss-of-function variants in CASP2 cause a neurodevelopmental lissencephaly–pachygyria syndrome linked to PIDDosome dysfunction [PMID:37880421].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"The initial identification of CASP2 (ICH-1/Nedd2) established it as a caspase family member capable of promoting apoptosis, with an alternatively spliced short isoform acting as a dominant-negative suppressor—resolving the question of whether a second mammalian ICE homolog participates in cell death.\",\n      \"evidence\": \"Overexpression of long and short isoforms in mammalian cells with serum deprivation and BCL-2 epistasis assays\",\n      \"pmids\": [\"8087842\", \"7958843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates unknown\", \"Mechanism of activation not addressed\", \"Relationship to mitochondrial pathway uncharacterized\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery of the RAIDD/CRADD adaptor answered how CASP2 is recruited to upstream death signaling: RAIDD bridges CASP2 (via CARD–CARD interaction) and RIP (via death domain), establishing the first model for a CASP2 activation platform.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation, and domain deletion mapping\",\n      \"pmids\": [\"8985253\", \"9044836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the upstream trigger that engages RAIDD was unknown\", \"Stoichiometry and structure of activation complex unresolved\", \"Whether RAIDD is required in vivo not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Structural and cell-biological studies resolved two key mechanistic questions: (1) the NMR structure of the RAIDD CARD revealed complementary charged surfaces mediating CARD–CARD interaction with CASP2, and (2) the CASP2 prodomain was shown to direct nuclear localization and to promote zymogen dimerization prior to autoprocessing.\",\n      \"evidence\": \"NMR structure with mutagenesis; GFP-prodomain fusions and subcellular fractionation; yeast dimerization assay with processing-deficient mutants\",\n      \"pmids\": [\"9695946\", \"9733748\", \"9506977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear function of caspase-2 versus cytoplasmic function not distinguished\", \"Structure of full-length CASP2 or its complex with RAIDD not solved\", \"Signal connecting nuclear CASP2 to mitochondrial permeabilization unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of golgin-160 as a Golgi-localized caspase-2-specific substrate revealed a non-nuclear function and explained how CASP2 contributes to Golgi fragmentation during apoptosis.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, in vitro cleavage assays, and cleavage-site mutagenesis\",\n      \"pmids\": [\"10791974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Golgi cleavage is required for cell death or is a bystander event\", \"Full substrate repertoire at the Golgi not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Three convergent studies placed CASP2 unambiguously upstream of mitochondria: active caspase-2 directly permeabilizes isolated mitochondria (releasing cytochrome c, AIF, Smac) and cleaves Bid, while pharmacological or genetic inhibition of CASP2 blocks cytochrome c release and downstream caspase-9/caspase-3 activation.\",\n      \"evidence\": \"Purified recombinant caspase-2 on isolated mitochondria; z-VDVAD-fmk and antisense; cell-free reconstitution; Bcl-2/Bcl-xL epistasis\",\n      \"pmids\": [\"12193789\", \"11832478\", \"12065594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CASP2 directly forms pores in mitochondrial membranes or requires Bax/Bak was unresolved\", \"Relative contributions of Bid cleavage versus direct permeabilization unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of the PIDDosome (PIDD–RAIDD–CASP2) as the physiological activation platform for caspase-2 answered how genotoxic stress triggers CASP2 activation: the p53-inducible protein PIDD scaffolds complex assembly.\",\n      \"evidence\": \"Native complex immunoprecipitation; PIDD overexpression and knockdown; caspase-2 activity assays under genotoxic stress\",\n      \"pmids\": [\"15073321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the PIDDosome is the sole activation mechanism for CASP2 or context-dependent\", \"Structural basis of the tripartite complex unknown at the time\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The finding that PIDD forms a separate PIDD–RIP1–NEMO complex that activates NF-κB independently of caspase-2 showed that the PIDDosome is a bifunctional signaling hub, and CASP2 is required only for its apoptotic output.\",\n      \"evidence\": \"RNAi of PIDD, RIP1, and CASP2; NF-κB reporter assays; NEMO modification analysis\",\n      \"pmids\": [\"16360037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the cell chooses between apoptotic and NF-κB-activating PIDDosome assemblies is unknown\", \"Post-translational signals governing complex switching not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The discovery that IRE1α RNase degrades miRNA precursors (miR-17, -34a, -96, -125b) that repress CASP2 translation during ER stress answered how CASP2 protein levels are acutely upregulated to commit cells to apoptosis under prolonged UPR signaling.\",\n      \"evidence\": \"Cell-free IRE1α cleavage of miRNA precursors; ribosome profiling; CASP2 protein quantification; miRNA mimic/inhibitor epistasis\",\n      \"pmids\": [\"23042294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional post-transcriptional regulators cooperate with IRE1α-mediated derepression\", \"Quantitative threshold of CASP2 protein needed for apoptosis commitment not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Genetic knockout and rescue experiments established an unexpected non-apoptotic role for CASP2 as an endogenous suppressor of autophagy via AMPK–mTOR and AMPK–MAPK pathways, expanding its function beyond cell death.\",\n      \"evidence\": \"Casp2 KO MEFs with re-expression rescue; LC3/p62 autophagy flux assays; AMPK/mTOR pathway inhibitors; ROS measurement\",\n      \"pmids\": [\"24879153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CASP2 directly cleaves an AMPK pathway component or acts indirectly through ROS\", \"In vivo physiological contexts in which CASP2-regulated autophagy is relevant remain unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human genetic evidence linked biallelic CASP2 loss-of-function to a neurodevelopmental lissencephaly–pachygyria syndrome, establishing CASP2 as essential for cortical development and phenocopying CRADD and PIDD1 deficiency.\",\n      \"evidence\": \"Exome sequencing of 7 patients from 5 families; RNA splicing validation of a splice-site variant; neuroimaging\",\n      \"pmids\": [\"37880421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro functional reconstitution of the truncating variants\", \"Mechanism by which PIDDosome dysfunction causes lissencephaly (apoptotic vs. non-apoptotic) unknown\", \"Animal model recapitulation not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the complete substrate repertoire of caspase-2, the structural basis of the full PIDDosome assembly, the mechanism by which CASP2 directly permeabilizes mitochondrial membranes, and how its apoptotic versus autophagy-suppressive functions are coordinated in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Full substrate spectrum not systematically mapped\", \"Cryo-EM or crystal structure of intact PIDDosome with CASP2 absent\", \"Whether CASP2-mediated autophagy suppression is relevant to the lissencephaly phenotype is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 4, 14, 16]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 4, 14, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 17]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 6, 15, 16, 17, 18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [21, 23]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"complexes\": [\n      \"PIDDosome (PIDD–RAIDD–CASP2)\"\n    ],\n    \"partners\": [\n      \"CRADD\",\n      \"PIDD1\",\n      \"BID\",\n      \"GOLGA3\",\n      \"ARC\",\n      \"RIPK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}